9:52 AM ET
8-K
Loan & Debt
Abvc Biopharma $4.11M Debt Financing with WallachBeth Capital, LLC
ABVC BioPharma entered into a securities purchase agreement for the sale of original issue discount senior convertible promissory notes in an aggregate principal amount of $4,106,060. The notes carry a 17.5% original issue discount, generating gross proceeds of $3.39 million, and mature on June 30, 2027. Proceeds will be used for working capital and to fund a $625,000 settlement payment to Lind Global Fund II LP.
- Value
- $4.11M
- Counterparty
- WallachBeth Capital, LLC
- Term
- through June 30, 2027